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A novel spot-on formulation combining permethrin, pyriproxifen and dinotefuran (Vectra
3DTM spot-on solution for dogs) was evaluated in adult Beagle dogs in a study to deter-
mine adulticidal efﬁcacy, egg laying inhibition and viability of Ctenocephalides felis felis
eggs (development and emergence of ﬂeas from the collected eggs). Prior to treatment six-
teen dogs were checked for their ability to keep ﬂeas 24hours after infestation and were
allocated to treatment groups: 8 dogs served as untreated controls, and 8 dogswere treated
once with the tested formulation. The spot on was administered respecting the laboratory
recommendations at a dosage of 65–126mg/kg of permethrin; 8.9–17.4mg/kg of dinotefu-
ran and 0.8–1.5mg/kg of pyriproxyfen. Each dogwas infestedwith 100 adult cat ﬂeas ready
to lay eggs after 72hours spent feeding on cats. Dogs were infested 24hours after treat-
ment and then weekly during 63 days. Eggs were collected and counted 24hours after each
infestation and dogs were combed 48hours after each infestation. Fleas were counted and
removed. Collected eggs were placed in incubator to study their development in larvae andlinical trial into newly emerged adults. A single treatment provided 99.7% adulticidal efﬁcacy on ﬂeas
within 48hours after treatment and controlled re-infestations for up to 30 days (efﬁcacy
>96.20%, p<0.05). The egg laying inhibition was over 92.3% for up to 29 days (p<0.05). The
adult emergence inhibition remained 100% during 8 weeks after treatment and was 99.8%
nine weeks after treatment (p<0.001).
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.. Introduction
The cat ﬂea Ctenocephalides felis felis, is the predominant
ea species found on dogs and cats worldwide (Franc et al.,
998; Alcaino et al., 2002; Gracia et al., 2007). Fleas can
ause severe disturbances for pets such as itching which,
hen severe, can lead to skin lesions, hair losses and for
usceptible animals ﬂea allergy dermatitis. Fleas can also
∗ Corresponding author. Tel.: +33 561193873; fax: +33 561193971.
E-mail address: m.franc@envt.fr (M. Franc).
304-4017/© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.
ttp://dx.doi.org/10.1016/j.vetpar.2012.07.014be vectors of several pathogens for cats such asMycoplasma
spp., Bartonella henselae, Rickettsia felis (Rolain et al., 2003;
Barrs et al., 2010; Hornok et al., 2010; Tsai et al., 2011) and
also the tapewormDipylidium caninum present in both cats
and dogs (Guzman, 1984).
Integrated approaches provide the best direct control of
ﬂea infestations on domestic animals as both adult ﬂeas on
pets and immature stages in the environment are targeted
(Jacobs et al., 2001; Rust, 2005; Beck et al., 2006). Most
topically applied ﬂea control products that offer integrated
control combine an adulticide with an insect growth reg-
ulator (IGR) (Young et al., 2004). IGRs affect development
y Parasi542 E. Bouhsira et al. / Veterinar
of eggs while they are still inside the adult ﬂeas or by direct
contact of eggs with hairs of treated pets. Once fallen off the
treated  animal into its environment, eggs will not hatch or
larvae  will die (Olsen, 1985; Beck and Pﬁster, 2004). These
combinations rarely allow to assess the efﬁcacy of IGRs
alone  because the adulticide eliminates ﬂeas before any
eggs  are produced throughout the ﬁrst weeks post treat-
ment.  Although relocation of mature ﬂeas from one host
to  another is possible (Franc and Cadiergues, 1997), this
transfer is rare in natural settings. To evaluate the ovici-
dal  activity of an adulticide–IGR combination, the study
design proposed by Franc et al. (2007) was adapted to
obtain  ready-to-lay eggs ﬂeas from cats and transferred to
dogs.
The  formulation evaluated was a combination of per-
methrin, dinotefuran and pyriproxyfen (Vectra 3DTM).
Dinotefuran is a third-generation rapid-acting nitroguani-
dine neonicotinoid insecticide exerting its action on
acetylcholine receptor presents in the insect nerve synapse.
Neonicotinoids are selective for insect acetylcholine recep-
tors  and have little afﬁnity for mammalian ones. Wakita
et  al. (2005) showed that dinotefuran had low afﬁnity
against binding sites of other neonicotinoids suggesting
a  different site of action for dinotefuran. Permethrin, the
ﬁrst  photostable synthetic pyrethroid, acts on the nervous
system of insects. It interferes with sodium channels to
disrupt  the function of neurons, and causes paralysis and
death  (Tomlin, 2006). Pyriproxyfen mimics speciﬁcally the
insect  juvenile hormone. It prevents ﬂea eggs from hatch-
ing/molting when applied on a newly laid egg and prevents
hatching of larvae of the 3rd stage into pupae (Meola et al.,
1996;  Miller et al., 1999).
This study design assessed the role of permethrin,
dinotefuran and pyriproxyfen treatment on ﬂea eggs
development into larvae and newly emerged adults. The
adulticidal effect was simultaneously evaluated.
2. Materials and methods
The  trial was performed according to Good Clinical
Practice (EEC III/3767/92 European Guideline (amended by
the  Directive 2004/28/CE)), VICH GL9 guideline relative to
Good  Clinical Practices. Animals were handled in compli-
ance  with the relevant Institutional Animal Care and with
the  Regional Ethic Committee for animal experimentation.
2.1. Animals
Sixteen healthy Beagle dogs (>5 years old) and 24 short-
haired cats (>5 years old) were included in this trial. Cats
were  selected to be used only as ﬂea-donors providing
engorged and gravid ﬂeas which had the opportunity to
feed  on them for 72 hours.
Animals used in this study had not been exposed to
ectoparasiticides within at least 3 months prior to treat-
ment  and were in good health throughout the study.Cats were housed in an indoor cattery where air was
exchanged 14 times per hour and the lighting was  12 hours
day/12  hours night. They received water and a dry cat food
ad  libitum.tology 190 (2012) 541– 546
Dogs were housed individually in kennels with natural
environmental lighting. They all had at their disposal an
individual ﬂea egg collecting pan used for sleeping. Dogs
were  fed a commercial dry dog food ration calculated to
maintain  the animal in a healthy physical state. Water was
available  ad libitum through automatic lickers present in
each  kennel. No concurrent medication was  given during
the  study. All animals were identiﬁed with the last four
numbers of their digital microchip.
2.2. Experimental design and methods
The 24 cats and the 16 dogs were acclimated to
study conditions for 15 days prior to treatment and were
observed daily for general health conditions. On day-7, each
of  the 16 dogs was infested with 100 C. f. felis harvested
from cats that had fed on them for the previous 72 hours.
On  day-6 eggs were collected from each dog individual pan
and  were counted. On the same day, ﬂea comb counts were
conducted to conﬁrm that all dogs had the same sensitivity
to  ﬂeas before treatment. Each dog was combed for at least
10  minutes by two  technicians using a ﬁne-toothed ﬂea
comb  (12 teeth/cm). Each animal’s entire coat was combed
thoroughly, and combing was stopped only after no ﬂea
was  found during the last minute of combing. If ﬂeas were
found,  combing continued until no ﬂea was found during
1  minute time frame. On day-5, eight replicates of two dogs
each  were formed based on descending pre-treatment ﬂea
counts.  Within replicates, dogs were randomly allocated to
control  or treated group. For allocation dogs were combed
24  hours after infestation.
2.2.1. Source of ﬂeas
The  C. felis strain used in this study was the laboratory
strain that has been maintained at the Parasitology Depart-
ment  of Toulouse Veterinary School. This colony originated
from  a wild strain harvested from a cat in the Toulouse area
and  has been maintained on cats under laboratory condi-
tions  since 1990. The strain has not been pressured with
any  insecticides since then.
2.2.2. Experimental procedure
24 cats were infested with approximately 150–200
unfed ﬂeas (50% male and 50% female ﬂeas aged between
5  and 10 days) and 72 hours after infestation ﬂeas were
carefully combed off the donor cats, assessed for mobility
and  viability and then pooled together. Healthy-appearing
ﬂeas with normal mobility were collected from the pool by
aspiration  and aliquoted in lots of 100 ﬂeas (approximately
50% male and 50% female). Then each aliquot of 100 ﬂeas
was  transferred to dogs on days −7, 1, 7, 14, 21, 28, 35, 42,
49,  56 and 63. D0 was treatment day.
Dogs (8 females) in the control group remained
untreated. Dogs in the treated group (1 castrated male
and  7 females) received the permethrin, pyriproxyfen and
dinotefuran combination (Vectra 3DTM spot-on solution for
dogs,  CEVA Animal Health, Rutherford, NJ). The pipettes
contained: permethrin 36.08% (w/w)  or 396.5 mg/ml  (w/v),
dinotefuran 4.95% (w/w) or 54.39 mg/ml  (w/v), pyriprox-
yfen 0.44% (w/w) or 4.83 mg/ml  (w/v) (ﬁnal formulation
density = 1.1). Two pipette presentations were used: 1.6 ml
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untreated animals maintained good ﬂea retention capac-
ity  throughout the study. Post-treatment arithmetic mean
ﬂea  counts for untreated control dogs ranged from 65.8
to  83.3 ﬂea counts for the treated dogs were signiﬁcantly
Table 1
Flea  counts 48 hours after infestation.
Study day Control group Treated group Efﬁcacy (%)
Day −6 81.3 (6.1) 81.3 (6.5) –
Day 3 77.5  (11.9) 0.3 (0.5) 99.7
Day 9 75.0 (14.4) 0 (0) 100
Day 16 72.3 (12.9) 0 (0) 100
Day 23 74.5 (15.8) 0.3 (0.7) 99.7
Day 30 65.8 (8.0) 2.5 (3.5) 96.2
Day 37 79.1  (9.1) 5.4 (8.9) 93.2
Day 44 83.3 (8.9) 10.1 (17.1) 87.8
Day 51 68.8 (11.9) 23.5 (25.2) 65.8E. Bouhsira et al. / Veterinar
nd 3.6 ml.  To follow laboratory recommendations, the
.6  ml  spot-on was applied directly to the skin in one point
etween the shoulder blades to dogs weighing between
.1 to 10.0 kg and the 3.6 ml  spot-on was applied directly
o  the skin in three points on the dorsal midline to dogs
eighing between 10.1 and 25.0 kg. Treated dogs weighed
etween 7.58 and 11.29 kg. They were treated at a dosage
f  65–126 mg/kg of permethrin; 8.9–17.4 mg/kg of dinote-
uran and 0.8–1.5 mg/kg of pyriproxyfen.
Live ﬂeas were removed and counted on days 3, 9,
6,  23, 30, 37, 44, 51, 58 and 65 (48 ± 3 hours after each
nfestation). Personnel conducting comb counts and car-
ng  for the animals were blinded to treatment group
llocations. To prevent cross-contamination between
reatment groups, separate ﬂea combs and lab coats were
sed  for each treatment group and were labelled as
uch. Gloves were changed systematically between each
og.
To  study the post-treatment ovicidal effect of the tested
ombination ﬂea eggs layed within 24 hours after ﬂeas
ere  placed on dogs were collected from each individual
ollected pan on days: 2, 8, 15, 22, 29, 36, 43, 50, 57 and 64
nd  counted the same day. As eggs were collected 24 hours
fter  each infestation time point, hatching into larvae did
ot  have time to occur. After eggs counts were recorded,
he ﬁrst 100 ﬂea eggs collected from each dog were placed
n  individual vials containing nutritive medium and placed
o  incubate for 4 weeks at 27 ◦C and 75–80% of humid-
ty to assess adult emergence. The remaining eggs (when
he  collected number was above 100) were placed in a
econd  vial containing nutritive medium and left to incu-
ate  in the same conditions as above for 7 days. Each vial
as  identiﬁed with the date, the study number and the
og  ID. After 7 days incubation new hatched larvae were
ounted.
.3.  Data analysis
.3.1.  Adulticidal efﬁcacy
Counts  of live adult ﬂeas after each combing was used to
alculate  the arithmetic mean of both treated and control
roups. Percent reduction from the control mean was  cal-
ulated  for the treated group at every post-treatment time
oint  using the formula:
 Efﬁcacy = arithmetic mean  control − arithmetic mean treated
arithmetic mean control
×100
.3.2. Egg laying inhibition
At  each egg collection time, counts of ﬂea egg collected
ere used for the calculation of arithmetic means of egg
ayed  for both treatment groups. Percent reduction from
he  control mean was calculated using the formula:%Egg laying inhibition
= arithmetic  mean control − arithmetic mean treated
arithmetic mean control
× 100tology 190 (2012) 541– 546 543
2.3.3. Egg hatching inhibition
The  mean number of larvae obtained after 7 days of
incubation of eggs (possible when the number of collected
eggs  was  above 100) was calculated for the both groups
and used for the calculation of the eggs hatching inhibition
as  given by the formula:
%Eggs  hatching inhibition
= arithmetic mean control − arithmetic mean treated
arithmetic mean control
× 100
2.3.4. Adults emergence inhibition
The mean number of adults obtained after 4 weeks of
incubation of eggs was calculated for the both groups and
used  for the calculation of the adult emergence inhibition
as  given by the formula:
%Adult  emergence inhibition
= arithmetic  mean control − arithmetic mean treated
arithmetic mean control
× 100
For each calculation, the treated group was  com-
pared to the control group using non parametric test of
Kruskal–Wallis. All testings were two-sided at the signiﬁ-
cance level  ˛ = 0.05. Analyses were performed using Systat
9  software.
3. Results
No adverse effects were observed in any dogs or cats
during the trial and Vectra 3DTM spot-on solution was
well tolerated by the 8 treated dogs. Four variables were
assessed during the study: adulticidal efﬁcacy; production
of  ﬂea eggs, eggs hatching ability into larvae and develop-
ment and emergence of ﬂeas from the collected eggs.
Adulticidal activity (Table 1, Fig. 1): All dogs included
in the study demonstrated adequate pre-treatment sensi-
tivity  to ﬂeas with ﬂea counts ranging from 71 to 92. AllDay 58 75.8  (9.0) 31.1 (27.8) 58.9
Day 65 80.4 (8.6) 36.5 (27.0) 54.6
Arithmetic mean (SD).
Day  0 = treatment day.
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s produFig. 1. Vectra 3DTM IGR activity, 48-hour adulticidal efﬁcacy, and total egg
combination  product on day 0.
lower than those for untreated control dogs at all post-
treatment evaluations (p < 0.05) (mean number of collected
ﬂeas  between 0 and 0.3 until day 23; 2.5 on day 30 and then
mean  ﬂea number increased steadily until the end of the
trial).  Vectra 3DTM spot-on solution for dogs controlled the
existing  ﬂea infestation providing 99.68% efﬁcacy within
48  hours after application. The treatment prevented dogs
from  new ﬂea infestations respectively with 100% efﬁcacy
on  day 9 and day 16, 99.7% on day 23 and 96.2% on day 30.
Then  the efﬁcacy decreased steadily.
Egg laying inhibition (Table 2, Fig. 1): Before treatment
the mean number of collected eggs per dog was 518.4 for
the  control group and 504.8 for the treated group (Table 2).
The  mean number of collected eggs remained statisti-
cally different (p < 0.05) between both groups until 57 days
post-treatment. The combination provided an egg laying
inhibition with an efﬁcacy over 92.3% during 4 weeks, over
80%  weeks 5 and 6, and over 60% weeks 7 and 8 post-
treatment.
Egg hatching inhibition: The study of eggs hatching
could only start on day 36. Indeed before that point the
Table 2
Flea  egg counts 24 hours after each ﬂea infestation and percentage of adult emerg
Study day Control 
Egg countsArith. mean (SD) Adult emergence (%
Day −6 518.4 (200.2) 27.9 
Day 2 451.5  (116.2) 51.6 
Day 8 408.3 (240.9) 36.6 
Day 15 463.1 (162.5) 34.9 
Day 22 359.3 (151.2) 24.8 
Day 29 368.9 (116.7) 44.9 
Day 36 606.4  (190.9) 46.9 
Day 43 519.9 (161.4) 58.5 
Day 50 630.8 (141.3) 43.9 
Day 57 524.5  (225.4) 38.4 
Day 64 499.6 (154.2) 56.3 
Day 0 = treatment day.
Arith. mean = arithmetic mean.ced following each infestation. Treated dogs received a single dose of the
number of eggs collected per dog was  100 or below 100
and  used for the adult emergence inhibition test. In the con-
trol  group the mean percentage of hatching was between
59.6% and 23.8%. In the treated group the larvae hatching
was  between 0 and 0.54%. So the inhibition of hatching pro-
vided  by spot-on solution was  between 99.1% and 100%
(data  not shown).
Adult  emergence inhibition (Table 2, Fig. 1): The inhibi-
tion of adult emergence was  100% during 8 weeks after the
treatment. On day 67 the inhibition was 99.8%.
4. Discussion
The originality of this work was based on the use of
ready-to-lay-eggs ﬂeas previously fed for 72 hours on cats.
This  study was adapted from the study design of Franc et al.
(2007)  that allowed for egg producing female ﬂeas to be
placed  onto treated dogs to assess the efﬁcacy of Vectra
3DTM spot-on solution for dogs on egg viability (hatching
into larvae, emergence into new viable adult). The model
was  successful in that 359–630 eggs were collected from
ence after 4 weeks incubation.
Treated
) Egg countsArith. mean (SD) Adult emergence (%)
504.8 (151.7) 26.6
19.9 (22.9) 0
8.0 (7.7) 0
6.8 (6.0) 0
9.6 (11.7) 0
28.4 (31.9) 0
87.1 (118.2) 0
92.4 (111.9) 0
219.6 (225.1) 0
194.1 (140.7) 0
302.9 (231.7) 0.1
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ach control dog in the weekly 24 hour collection periods
after an infestation with 100 ﬂeas). In this trial an impor-
ant  decrease of egg production was observed in treated
ogs even if ﬂeas were already producing eggs before being
ransplanted to dogs (Fig. 1). This can be explained by the
apid  mortality of ﬂeas due to a direct action of dinote-
uran associated with permethrin. This is the ﬁrst study
n  egg viability with this formulation. The mean number
f  newly emerged adult ﬂeas after 28 days incubation of
00  collected eggs was between 24.8 and 58.5 in the con-
rol  group (Table 2). The inhibition of hatching provided by
ectra  3DTM spot-on solution for dogs was between 99.1%
nd  100% during the 8 weeks post treatment. These results
re  similar with those obtained by Young et al. (2004) with
 combination of ﬁpronil and another insect juvenile hor-
one,  the (S)-methoprene. They obtained an egg hatching
eduction of 89.1% and an inhibition of new adult emer-
ence of 93.1% 64 days post-treatment.
The adulticidal efﬁcacy of Vectra 3DTM evaluated
8 hours after each infestation ranged from 96.2 to 100%
ithin  the 30 ﬁrst days post-treatment then the efﬁcacy
ecreased progressively: 93.2% (day 37), 87.8% (day 44),
5.8%  (day 51), 58.9% (day 58) and 54.6% (day 65). It appears
here  was animal to animal variations after the claimed
fﬁcacy period of the Vectra 3DTM. Until day 30 post-
reatment the variation around mean of alive ﬂeas combed
n  dogs was under 3.5, in adequation with results observed
n  other efﬁcacy trials. From day 30 until the end of the
tudy S.D. increase because the adulticidal efﬁcacy of Vec-
ra  3D decreases and ﬂeas are more and more found alive
n  treated dogs. The variation of efﬁcacy between treated
ogs  can be explained by the ability of hairs retention of
he  product which is correlated to a variable sebum pro-
uction from one animal to an other. The variation around
ean  of collected eggs can be correlated to the behaviour
f  dogs in their kennel and the time each dog spends on
ts  collecting pan per 24 hours, as it was used for sleeping.
he amount of eggs collected was more important for dogs
pending more time sleeping on their pan. For one single
og  the resting behaviour was variable from one week to
he  other.
Dinotefuran was discovered in 1993 (Wakita et al.,
005) but there are few trials studying its efﬁcacy toward
dult  ﬂeas. The ﬁrst published study evaluating the
4  hour-efﬁcacy on adult ﬂeas of action of dinotefuran
Vectra for cats and kittens) was performed on cats by
urphy et al. (2009). The adulticidal efﬁcacy was between
8.5  and 100% until day 30. Dryden et al. (2011) evaluated
n  dogs the efﬁcacy of Vectra 3DTM 6 hours after ﬂea infes-
ations. The efﬁcacy ranged between 92.3% and 100% during
he  28 days of that study. The results of these previously
ublished studies are similar with those obtained in this
tudy.
The  association of dinotefuran, permethrin and
yriproxyfen effectively broke the life cycle of ﬂeas,
ncluding larvae and adults..  Conclusion
This clinical trial was the ﬁrst reported trial using gravid
nd  ready to lay egg producing ﬂeas obtained from cats andtology 190 (2012) 541– 546 545
transferred  to dogs. This original study design permitted
the evaluation of the ovicidal efﬁcacy of the tested combi-
nation.
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